US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.
US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.
<iframe src="https://hindustansphere.com/embed/cluster/e451c577d562ea268e7674852ab4ef8790d40d5e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive"></iframe>
